Fleet oral liquid laxative3/13/2024 ![]() There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. However, elderly patients may be more sensitive to the effects of OsmoPrep® tablets than younger adults, and are more likely to have age-related kidney problems, which may require caution for patients receiving this medicine. GeriatricĪppropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of OsmoPrep® tablets in the elderly. Safety and efficacy have not been established. PediatricĪppropriate studies have not been performed on the relationship of age to the effects of OsmoPrep® tablets in the pediatric population. For non-prescription products, read the label or package ingredients carefully. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. For this medicine, the following should be considered: Allergies This is a decision you and your doctor will make. In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This medicine is available only with your doctor's prescription. This helps your doctor see the inside of your colon more clearly during the colonoscopy. This medicine works by cleaning your colon and causing you to have diarrhea. ![]() Sodium phosphate dibasic and sodium phosphate monobasic combination is used to clean or empty your bowels before an imaging procedure called colonoscopy. Visicol(R): It is important to use the dose and dosing regimen as recommended (pm/am split dose). Avoid additional sodium phosphate-based purgative or enema products. Prep(R): Advise patients of the importance of following the recommended split dosage regimen and the importance of adequate hydration before, during and after the use of sodium phosphate, dibasic and sodium phosphate, monobasic. However, cases have occurred in patients with no identifiable risk factors. ![]() These include diuretics, ACE inhibitors, angiotensin receptor blockers (ARBs), and possibly NSAIDs. Use of medications that may impair renal perfusion or function may also increase risk. Risk factors for developing acute phosphate nephropathy include increased age, hypovolemia, renal impairment, bowel obstruction, or active colitis. Acute phosphate nephropathy has been reported in association with the use of oral sodium phosphate products, some cases resulting in permanent impairment of renal function, including cases requiring long-term dialysis.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |